Tuesday, June 02, 2020 7:13:07 PM
Sativex made it to Phase 3 and failed at mitigating pain in cancer patients. It was no more effective than a placebo. Millions of dollars spent and it failed the FDA approved clinical trials. That is exactly why no one is going to buy a unproven drug patent for billions of dollars - it never happens.
The OWCP psoriasis patent is in no way a billion dollar patent. And there won't be a Class Action Lawsuit as OWCP doesn't have any assets to attach. Generally only the attorneys benefit in Class Action complaints.
So you are suggesting that Riterband perjured himself in Federal Court by saying the company doesn't have the financial resources to provide audited financials.
"One thing is for certain, we’ll all know the answer very soon! I personally think we’ll see compliance from Ritterband on Friday and a buyout announcement."
IG
"And the CEO looked, and behold a pale horse: and his name that sat on him was Death to Scams, and Hell followed with him."
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM